Related references
Note: Only part of the references are listed.Dietary intake, food addiction and nutrition knowledge in young people with mental illness
Scott B. Teasdale et al.
NUTRITION & DIETETICS (2020)
Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits
Yang Tian et al.
SCHIZOPHRENIA RESEARCH (2020)
Dietary intake of people with severe mental illness: systematic review and meta-analysis
Scott B. Teasdale et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis
Parita Shah et al.
SCHIZOPHRENIA RESEARCH (2019)
Pathways linking obesity to neuropsychiatric disorders
Lais Bhering Martins et al.
NUTRITION (2019)
Obesity and cardiovascular disease: revisiting an old relationship
Chrysi Koliaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
The role of genetic testing in dyslipidaemia
Amanda J. Berberich et al.
PATHOLOGY (2019)
Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study
Roman Balotsev et al.
EARLY INTERVENTION IN PSYCHIATRY (2019)
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
J. Westman et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2018)
Obesity, dyslipidemia and brain age in first-episode psychosis
Marian Kolenic et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update
Marie-Eve Piche et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Dietary patterns and physical activity in people with schizophrenia and increased waist circumference
Ane Storch Jakobsen et al.
SCHIZOPHRENIA RESEARCH (2018)
Changes in metabolism and microbiota after 24-week risperidone treatment in drug naive, normal weight patients with first episode schizophrenia
Xiuxia Yuan et al.
SCHIZOPHRENIA RESEARCH (2018)
Stress and Obesity: Are There More Susceptible Individuals?
Eline S. van der Valk et al.
CURRENT OBESITY REPORTS (2018)
Proinflammatory cytokines remain elevated despite long-term remission in Cushing's disease: a prospective study
Nirali Shah et al.
CLINICAL ENDOCRINOLOGY (2017)
Cardiovascular disease in patients with schizophrenia
Leonard Kritharides et al.
MEDICAL JOURNAL OF AUSTRALIA (2017)
The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia
Qiongzhen Li et al.
PSYCHIATRY RESEARCH (2017)
IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling
Katharina Timper et al.
CELL REPORTS (2017)
Individual Factors Affecting Self-esteem, and Relationships Among Self-esteem, Body Mass Index, and Body Image in Patients With Schizophrenia
EunJung Oh et al.
ARCHIVES OF PSYCHIATRIC NURSING (2017)
Twenty-year progression of body mass index in a county-wide cohort of people with schizophrenia and bipolar disorder identified at their first episode of psychosis
Martin Strassnig et al.
BIPOLAR DISORDERS (2017)
Evaluation of an inpatient psychiatric hospital physician education program and adherence to American Diabetes Association practice recommendations (Reprinted from Journal of Health-System Pharmacy Residents JHPR, vol 2, issue 1, 2013)
Robin L. Koffarnus et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Diabetes and Schizophrenia
Jaana Suvisaari et al.
CURRENT DIABETES REPORTS (2016)
Methicillin resistant Staphylococcus aureus (MRSA) in Malwa region of Punjab (North-West India)
Neerja Jindal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia
Qiongzhen Li et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Obesity and Prevalence of Cardiovascular Diseases and Prognosis-The Obesity Paradox Updated
Carl J. Lavie et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2016)
Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits
D. C. Chen et al.
PSYCHOLOGICAL MEDICINE (2016)
Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps
Beibei Zhang et al.
SCHIZOPHRENIA RESEARCH (2016)
How sedentary are people with psychosis? A systematic review and meta-analysis
Brendon Stubbs et al.
SCHIZOPHRENIA RESEARCH (2016)
Cardiovascular diseases among patients with schizophrenia
Muhammad Chanchal Azad et al.
ASIAN JOURNAL OF PSYCHIATRY (2016)
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
P. Manu et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Obesity correlates with fewer symptoms in schizophrenia treated with long-term clozapine: Gender difference
Li Hui et al.
PSYCHIATRY RESEARCH (2015)
Metabolic syndrome in drug-naive and drug-free patients with schizophrenia and in their siblings
Asli Enez Darcin et al.
SCHIZOPHRENIA RESEARCH (2015)
Mental illness and metabolic syndrome - a literature review
Urszula J. Lopuszanska et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2014)
Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
Xueqin Song et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2014)
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Un Ju Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Activation of Th17 cells in drug naive, first episode schizophrenia
Minli Ding et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia
Song Chen et al.
PSYCHIATRY RESEARCH (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Behavioral Interventions for Antipsychotic Induced Appetite Changes
Ursula Werneke et al.
CURRENT PSYCHIATRY REPORTS (2013)
Dyslipidemia in Obesity: Mechanisms and Potential Targets
Boudewijn Klop et al.
NUTRIENTS (2013)
Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
T. A. P. Lett et al.
MOLECULAR PSYCHIATRY (2012)
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants
Mariel M. Finucane et al.
LANCET (2011)
Adipose Tissue Gene Expression of Factors Related to Lipid Processing in Obesity
Mercedes Clemente-Postigo et al.
PLOS ONE (2011)
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Robert J. Fountaine et al.
OBESITY (2010)
Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms
Gavin P. Reynolds et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Insulin resistance and metabolic profile in antipsychotic naive schizophrenia patients
Anindya Dasgupta et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population
Rocio Perez-Iglesias et al.
SCHIZOPHRENIA RESEARCH (2009)
Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders - A systematic critical reappraisal
Mario Alvarez-Jimenez et al.
CNS DRUGS (2008)
Predictors of antipsychotic-induced weight gain in first-episode psychosis - Conclusions from a randomized, double-blind, controlled prospective study of olonzopine, risperidone, and holoperidol
Sahoo Saddichha et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Adiposity and eating behaviors in patients under second generation antipsychotics
Melissa Blouin et al.
OBESITY (2008)
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls
Jerome Brunelin et al.
SCHIZOPHRENIA RESEARCH (2008)
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: One-year analysis
Martin Strassnig et al.
SCHIZOPHRENIA RESEARCH (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents
Igor Elman et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia
JH Thakore et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia
DJ Walder et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
